The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

Dame Emma Walmsley prides herself on her tenacity. It is something the GSK chief says she inherited from her late father, a ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its pipeline ahead of a key ...

The pharma giant has operated in Ireland for decades and continues to have operations in key locations such as Cork and ...